China Diabetes Devices Market: Industry Analysis and Forecast (2024-2030)

The China Diabetes Devices Market size was valued at USD 6.80 Billion in 2023 and the total China Diabetes Devices Market revenue is expected to grow at a CAGR of 5.3 % from 2023 to 2030, reaching nearly USD 9.76 Billion.

Diabetes Device Market in China Overview

China Diabetes Devices Market profits are estimated to contribute to 5.3 % of industry revenue in 2030. This robust growth is driven by factors such as the growing prevalence of diabetes, rising disposable incomes, and governmental initiatives supporting diabetes management. However, the overall Chinese healthcare expenditure is expected to reach $1.10 trillion by 2030, reflecting a significant commitment to medical advancements. In China, the diabetes device ecosystem claims a substantial and expanding workforce, with projections exceeding 1 million individuals employed. This includes roles in research and development, manufacturing, distribution, sales, and healthcare professionals dedicated to diabetes management. According to MMR studies, Forecasts indicate that the prevalence of diabetes is going to keep rising in the coming years. It is specified that there are expected to be 133 million adults living with diabetes worldwide significant increase of 29 million individuals. China Diabetes Devices MarketTo know about the Research Methodology :- Request Free Sample Report

The table shows the Impact of Diabetes on Adults in China (2023)

Aspect Statistics Impact
1. Prevalence 133 million adults with diabetes 1 in 10 adults living with diabetes
2. Type Breakdown Type 1: 5% Minor contributor, but requires specialized management.
 Type 2: 90% Dominant type, linked to lifestyle factors and rising prevalence.
Gestational: 5% This can lead to Type 2 diabetes later in life.
3. Economic Burden -$100 billion in annual healthcare costs Significant strain on individuals and the healthcare system.
4. Health Complications Increased risk of cardiovascular diseases by 3 times Heart attacks, strokes, and other cardiac issues.
Blindness risk is 2-5 times higher Vision loss and the potential need for assistance.
People are Embracing Personalizes Diabetes Care in China Patients are increasingly demanding more proactive and collaborative management strategies from their healthcare providers. The rise of diabetes management apps and online communities empowers patients to actively participate in their care and share experiences with others on similar journeys. According to MMR estimation, the worldwide market for personalized medicine which includes diabetes treatment is expected to grow to be worth more than $380 billion by 2030. This is expected to fuel research and development efforts in personalized medicine, leading to new diagnostic tools, targeted therapies, and AI-powered algorithms for patient care. Challenges Faced by the Chinese Government for the Diabetes Device Market The Cost of Diabetes devices has been a significant barrier for many patients. Affordability issues may limit the adoption of advanced devices, leading to a reliance on more traditional and less expensive methods for managing diabetes. Integrating the latest technologies into diabetes devices, such as artificial intelligence and continuous glucose monitoring, requires significant investments. For Example, Financial incentives for domestic companies developing AI-powered diabetes devices. Also, China launched the Pilot Program in 2023 to provide free CGM (Continuous Glucose Monitoring) systems to patients with type 1 diabetes in selected regions. This program aims to evaluate the impact of CGM on glycemic control, and patient satisfaction, and reduce healthcare costs. Supportive Schemes by the Chinese Government for Diabetes Device Manufacturing 1. The "Healthy China 2030" initiative: This initiative includes a focus on improving diabetes prevention and control. 2. The "Essential Medicines List": This list includes some diabetes devices that are covered by the National Medical Insurance scheme. 3. The "Special Assistance Program for Chronic Diseases": This program provides financial assistance to low-income patients with chronic diseases, including diabetes. China Diabetes Devices Market

China Diabetes Device Market Segment Analysis

Blood Glucose Monitoring (BGM) Devices segment holds a dominant position, accounting for 63% of the total market value in 2023. Supportive policies of the Chinese government and reimbursement programs for BGMs, particularly targeting rural areas, boost China Diabetes Device Market access and affordability. The estimated number of Blood Glucose Monitoring users in China is around 68 million adults and annual sales of BGM have reached over 103 million units.

China Diabetes Devices Market Scope: Inquire Before Buying

China Diabetes Devices Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 6.80 Bn.
Forecast Period 2024 to 2030 CAGR: 5.3% Market Size in 2030: US $ 9.76 Bn.
Segments Covered: by Device Type Blood Glucose Monitoring Devices Insulin Delivery Devices
by Distribution Channel Retail Pharmacies Online Platforms

Key Manufacturers in China Diabetes Devices Market

1. Abbott 2. Medtronics. 3. Roche. 4. Becton, Dickinson & Company. 5. Dexcom. 6. Lepu Medical Technology (CN) 7. MicroPort (CN) 8. Johnson & Johnson 9. Medtronic 10. Ascensia Diabetes Care Frequently Asked Questions: 1. What is the growth rate of China Diabetes Devices Market? Ans: The China Diabetes Devices Market is growing at a CAGR of 5.3% during forecasting period 2024-2030. 2. What is scope of the China Diabetes Devices Market report? Ans: China Diabetes Devices Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 3. Who are the key players in China Diabetes Devices Market? Ans: The important key players in the China Diabetes Devices Market are – Abbott, Medtronics., Roche., Becton, Dickinson & Company., Dexcom., Lepu Medical Technology (CN), MicroPort (CN), Johnson & Johnson, Medtronic, Ascensia Diabetes Care. 4. What is the study period of this Market? Ans: The China Diabetes Devices Market is studied from 2023 to 2030.
1. Diabetes Device Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. China Diabetes Device Market: Dynamics 2.1. China Diabetes Device Market Trends 2.2. PORTER’s Five Forces Analysis 2.3. PESTLE Analysis 2.4. Value Chain Analysis 2.5. Challenges and Opportunities in the Diabetes Device Market in China 2.6. Regulatory Landscape of China Diabetes Device Market 2.7. Technological Advancements in China Diabetes Device Market 2.8. Factors Driving the Growth of the Diabetes Device Market 2.9. Personalized Diabetes Care in China 2.10. Diabetes Impact on the Healthcare Sector of China 2.11. Government Funding for the prevention of Diabetes 2.12. Initiative Focus on Manufacturing and Control of Diabetes 2.13. Key Opinion Leader Analysis for China Diabetes Device Industry 2.14. Analysis of Government Schemes and Initiatives for China Diabetes Device Industry 2.15. The Global Pandemic Impact on the China Diabetes Device Market 2.16. China Diabetes Device Market Price Trend Analysis (2022-23) 3. China Diabetes Device Market: Market Size and Forecast by Segmentation for (by Value in USD Million) (2023-2030) 3.1. China Diabetes Device Market Size and Forecast, by Device Type (2023-2030) 3.1.1. Blood Glucose Monitoring Devices 3.1.2. Insulin Delivery Devices 3.2. China Diabetes Device Market Size and Forecast, by Distribution Channels (2023-2030) 3.2.1. Retail Pharmacies 3.2.2. Online Platforms 4. China Diabetes Device Market: Competitive Landscape 4.1. MMR Competition Matrix 4.2. Competitive Landscape 4.3. Key Players Benchmarking 4.3.1. Company Name 4.3.2. Product Segment 4.3.3. End-user Segment 4.3.4. Revenue (2023) 4.4. Market Analysis by Organized Players vs. Unorganized Players 4.4.1. Organized Players 4.4.2. Unorganized Players 4.5. Leading China Diabetes Device Market Companies, by market capitalization 4.6. Market Trends and Challenges in China 4.6.1. Technological Advancements 4.6.2. Affordability and Accessibility 4.6.3. Shortage of Skilled Professionals 4.7. Market Structure 4.7.1. Market Leaders 4.7.2. Market Followers 4.7.3. Emerging Players in the Market 4.7.4. Opportunities for Growth 4.8. Mergers and Acquisitions Details 5. Company Profile: Key Players 5.1. Abbott. 5.1.1. Company Overview 5.1.2. Business Portfolio 5.1.3. Financial Overview 5.1.4. SWOT Analysis 5.1.5. Strategic Analysis 5.1.6. Details on Partnership 5.1.7. Potential Impact of Emerging Technologies 5.1.8. Regulatory Accreditations and Certifications Received by Them 5.1.9. Strategies Adopted by Key Players 5.1.10. Recent Developments 5.2. Medtronics. 5.3. Roche. 5.4. Becton, Dickinson & Company. 5.5. Dexcom. 5.6. Lepu Medical Technology (CN) 5.7. MicroPort (CN) 5.8. Johnson & Johnson 5.9. Medtronic 5.10. Ascensia Diabetes Care 6. Key Findings 7. Industry Recommendations 8. China Diabetes Device Market: Research Methodology